» Articles » PMID: 39811558

Remote Monitoring of Patients with COPD Disease Using a Tablet System: a Randomised Crossover Study of Quality-of-life Measurements

Overview
Journal ERJ Open Res
Date 2025 Jan 15
PMID 39811558
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Remote patient monitoring (RPM) has been evaluated in COPD, but with varying results. We aimed to evaluate whether a tablet system that monitors disease-related parameters in patients with COPD could influence physical and mental health-related quality of life, compared with usual care (UC).

Methods: 70 patients with Global Initiative for Chronic Obstructive Lung Disease (GOLD) group D COPD (61% women, aged 71±8 years, forced expiratory volume in 1 s % predicted 41±13%, COPD Assessment Test (CAT) 19±7 points) were recruited at the COPD centre in Gothenburg, Sweden, and randomised to a tablet-based RPM system or UC for a 26-week period, after which they crossed over to the alternative management for another 26 weeks. The Short Form-12 (SF-12) (primary outcome), CAT, modified Medical Research Council (mMRC) Dyspnoea Scale, EuroQol-5 Dimensions (EQ-5D) and Hospital Anxiety and Depression Scale (HADS) were evaluated at four visits. Exacerbations were continuously reported, as was adherence to RPM.

Results: 59 patients completed the study: 28 patients randomised to start with UC and 31 randomised to start with RPM. The changes in the SF-12 Physical Component Summary (PCS) (UC: -1.17±6.90 RPM: -1.06±8.15) and Mental Component Summary (MCS) (UC: 0.63±11.14 RPM: -0.63±8.15), as well as in CAT, the mMRC scale, the EQ-5D, HADS anxiety, HADS depression and number of exacerbations, were similar in both intervention periods. Neither the 26-week UC period nor the intervention significantly affected the measured outcomes. There was a 95% adherence rate during RPM.

Conclusions: A 26-week tablet-based RPM system that monitors CAT, oxygen saturation, blood pressure, pulse, weight and physical activity, connected to a case manager, is feasible and safe, but did not influence health-related quality of life in patients with COPD GOLD D.

References
1.
Tupper O, Gregersen T, Ringbaek T, Brondum E, Frausing E, Green A . Effect of tele-health care on quality of life in patients with severe COPD: a randomized clinical trial. Int J Chron Obstruct Pulmon Dis. 2018; 13:2657-2662. PMC: 6122889. DOI: 10.2147/COPD.S164121. View

2.
Mao A, Tam L, Xu A, Osborn K, Sheffrin M, Gould C . Barriers to Telemedicine Video Visits for Older Adults in Independent Living Facilities: Mixed Methods Cross-sectional Needs Assessment. JMIR Aging. 2022; 5(2):e34326. PMC: 9066341. DOI: 10.2196/34326. View

3.
Rabin R, de Charro F . EQ-5D: a measure of health status from the EuroQol Group. Ann Med. 2001; 33(5):337-43. DOI: 10.3109/07853890109002087. View

4.
Zigmond A, SNAITH R . The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983; 67(6):361-70. DOI: 10.1111/j.1600-0447.1983.tb09716.x. View

5.
McDowell J, McClean S, FitzGibbon F, Tate S . A randomised clinical trial of the effectiveness of home-based health care with telemonitoring in patients with COPD. J Telemed Telecare. 2015; 21(2):80-7. DOI: 10.1177/1357633X14566575. View